Majid Momeny

9PUBLICATIONS
27CO-AUTHORS
Medical infection agents (incl. prions)RehabilitationMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 27, 2025
RBM39 Contributes to MGMT Maintenance in Response to Temozolomide-Induced DNA Damage.

Vahid Khalaj, Jack T Adams, Solmaz AghaAmiri

|Apr 18, 2025
Therapeutic Effects of Bovine Colostrum on Bone Healing, Rehabilitation, and Postoperative Complications: A Prospective, Randomized, Double-Blinded Comparative Trial.

Faezeh Gouhari, Zahra Vahdat Shariatpanahi, Shahin Talebi

|Jan 25, 2025
SSTR2-Targeted Theranostics in Hepatocellular Carcinoma.

Majid Momeny, Solmaz AghaAmiri, Servando Hernandez Vargas

|Jul 22, 2024
Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies.

Atieh Pourbagheri-Sigaroodi, Majid Momeny, Nima Rezaei

|May 10, 2021
Synergistic effects of BKM120 and panobinostat on pre-B acute lymphoblastic cells: an emerging perspective for the simultaneous inhibition of PI3K and HDACs.

Mahdieh Mehrpouri, Majid Momeny, Davood Bashash

|Apr 08, 2021
Druggable cancer phosphatases.

Julia P Vainonen, Majid Momeny, Jukka Westermarck

Pageof 2